Clinical Trial Update: IL-32 Levels in Patients With Chronic Periodontitis [Phase 1]

View source ↗

Summary

This completed Phase 1 clinical trial evaluated levels of interleukin-32 (IL-32) in patients with chronic periodontitis to explore its role in the disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Snippet

Sponsor: Bulent Ecevit University | Conditions: Periodontitis | Phase 1 | Status: COMPLETED